West Pharmaceutical Services (WST) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on West Pharmaceutical Services (WST) is Neutral.

The composite score behind that read is +0.10, weighing +0.19 of bullish evidence against -0.10 bearish.

West Pharmaceutical Services last closed at $366.00, +0.75% on the session.

Against the IVW growth benchmark the position is -0.05% over the forecast window.

The read is built from 15 underlying insights — 5 bullish and 10 bearish.

Agreement across those insights is 33%.

West Pharmaceutical Services has no graded predictions yet. We publish our accuracy across thousands of stocks in the open, misses included.

On the fundamentals StockMap ranks West Pharmaceutical Services in the 15th percentile on valuation and the 78th percentile on return on equity, where 100 is best.

West Pharmaceutical Services is classified under Health Care / Life Sciences Tools & Services, with a market capitalisation of $25.57B.

StockMap tracks West Pharmaceutical Services as the 8th largest of the 41 companies it covers in the Life Sciences Tools & Services industry, part of the Health Care sector.

Across that group the current two-week reads are 37 Neutral, 2 Moderate Outperform and 2 Moderate Underperform.

On that composite West Pharmaceutical Services ranks 13th of 41 in the group, against a group median of +0.06.